CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase II Trial Comparing Biomarker Directed Therapy Versus Clinician's Choice of Enzalutamide or Docetaxel in Patients With Advanced Prostate Cancer Post Abiraterone

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04015622
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:25.692834+00:00
Published At: 2025-08-20T00:00:00+00:00
Record Updated At: 2025-08-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Castration-Resistant Prostate Cancer (mCRPC)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-08-20"
protocolSection.identificationModule.nctId: "NCT04015622"
protocolSection.identificationModule.officialTitle: "A Randomized Phase II Trial Comparing Biomarker Directed Therapy Versus Clinician\u0027s Choice of Enzalutamide or Docetaxel in Patients With Advanced Prostate Cancer Post Abiraterone"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.